ArticleThe Journal of urology2018

Re: Fexapotide Triflutate: Results of Long-Term Safety and Efficacy Trials of a Novel Injectable Therapy for Symptomatic Prostate Enlargement.

Steven A KaplanPubMed ↗Publisher ↗

No numbers read from the abstract.